Consider shorting speculative technology, particularly "worthless" quantum computing stocks like IONQ, RGTI, QBTS, and BTQ. The highest conviction short is Rigetti Computing (RGTI), which is viewed as a prime candidate to fall significantly further. Another high-conviction short is Beyond Meat (BYND), based on its fundamentally broken business model of selling products for less than they cost to make. For a bullish opportunity, consider buying Sarepta Therapeutics (SRPT), which is seen as a high-quality pharmaceutical company trading at an attractive low valuation. Finally, Palantir (PLTR) is presented as a quality long-term holding with a strong business model that should not be shorted.

General Market & Risk Assets

• The speaker has a broadly bearish outlook on the market, stating, "I'm short all the risk assets, so basically just being short the market."
• He believes that "very risky kind of frontier technology companies" are overvalued and will continue to crash.
• He advises investors to think about long-term investing and avoid the "impatience" that leads to losses, particularly with speculative assets.

Takeaways

• The speaker holds a significant short position against the broader market, with a particular focus on speculative technology sectors.
• This suggests a belief that a market correction or downturn is likely, especially for companies with unproven business models or those in "frontier" industries.
• Investors are cautioned against chasing "instant gratification" in high-risk stocks.

Quantum Computing Sector (Overall Theme)

• The speaker is extremely bearish on the entire publicly traded quantum computing sector, referring to the companies as the "four horsemen of Quantum" and stating they are part of a "quantum bubble."
• He believes these companies are "worthless" and that he has a significant "edge" in shorting them.
• The core of his thesis is that these companies have no viable products, no revenue, and no realistic path to success. He states, "I just want to know is it real or is it fake... most of these companies out there are fake."
• He has been actively shorting these stocks, increasing his position as they fall, and views any rallies as opportunities to add to his short positions.

Takeaways

• The speaker views the quantum computing sector as a speculative bubble filled with fraudulent or worthless companies.
• He is taking an aggressive short position against multiple companies in this space, including IONQ, RGTI, QBTS, and BTQ.
• This is a high-conviction, high-risk trade. While he has experienced pain with the stocks rallying against him, he is confident in his long-term thesis that they will ultimately go to zero or near-zero.

IonQ (IONQ)

• The speaker is extremely bearish on IonQ, calling it a "massive short."
• It is his second-biggest short position after Rigetti.
• He mentions that even after a significant drop from its peak, he believes there is still substantial downside.

Takeaways

• IonQ is a core part of the speaker's bearish thesis on the quantum sector.
• He believes the company is fundamentally overvalued and is a prime short-selling candidate.

Rigetti Computing (RGTI)

• The speaker is extremely bearish on Rigetti, stating it is his "biggest short."
• He mentions buying puts on the stock and believes it has a long way to fall, stating at one point, "Rigetti has to go to like five, man."
• He views any upward price movement as a "pop" to short into.

Takeaways

• Rigetti is the speaker's primary target for his short-selling strategy in the quantum space.
• He is actively trading against the stock, using options (puts) to express his bearish view.

D-Wave / Quantum Computing Inc. (QBTS)

• The speaker is extremely bearish, lumping QBTS in with other quantum stocks he considers fraudulent or worthless.
• He explicitly states, "Bro, never buy the stock of a fraudulent company," in reference to QBTS.
• He mocks the idea of buying the stock and mentions adding to his short position.

Takeaways

• The speaker considers QBTS to be a fraudulent company and a clear short.
• Investors are strongly warned against buying the stock.

BTQ Technologies (BTQ)

• The speaker is extremely bearish, calling BTQ "even more fraudulent" than QBTS and "worthless."
• He mocks the narrative of it being a "quantum Bitcoin," pointing to its poor stock performance as evidence that the story is not playing out.
• A significant portion of the podcast involves a debate with a person who is bullish on BTQ. The bull's case rests on potential defense contracts and stablecoin applications.
• The speaker refutes this by pointing out the company's minimal R&D spending ($2.5 million in 2024), lack of revenue, and the fact that its proposed technologies (like post-quantum cryptography) are largely open-source and don't require proprietary hardware.
• He concludes it's more of a "business plan than a company" and is massively overvalued for a pre-revenue startup.

Takeaways

• Despite hearing a bullish case, the speaker remains firmly short BTQ.
• His view is that the company lacks proprietary technology, has no revenue, and is valued as a successful company rather than the early-stage, high-risk venture it is.
• He believes the stock is a clear short candidate within the quantum theme.

Oklo (OKLO)

• The speaker is bearish on Oklo, a nuclear technology company.
• He groups it with other "frontier technology companies" that he believes are "all going to zero."
• He notes that Oklo and other "risk on assets are selling off," which benefits his short portfolio.

Takeaways

• Oklo is part of the speaker's broader short thesis against speculative, pre-revenue technology companies.
• He expects the stock to continue to decline significantly.

CLS Holdings (CLSQ)

• The speaker is extremely bearish, stating "CLSQ is going to go bankrupt. We are short CLSQ."
• He describes it as a "fake-ass company" that pivots between buzzwords like NFTs, IoT, and quantum without having any real products or revenue.
• He believes the company's sole purpose is to "pay the CEO" and "rinse retail" investors.

Takeaways

• The speaker views CLSQ as a quintessential example of a company to short-sell.
• He warns that anyone who likes the stock is "missing a lot of brain cells" and will get a lesson they "will never forget."

Sarepta Therapeutics (SRPT)

• The speaker is bullish on Sarepta.
• He has taken a long position, stating, "I bought some Sarepta calls. I'm going to buy some more. I have shares too."
• He later uses it as an example of a good investment, noting it trades at a very low valuation ("one or two times sales") for a pharmaceutical company, suggesting a disproportionately high probability of profit.

Takeaways

• The speaker sees a significant long opportunity in SRPT, using both shares and call options to express his bullish view.
• The investment thesis is based on what he perceives as a very attractive valuation for a drug company with valuable assets.

Revolution Medicines (RBMD)

• The speaker is bullish on RBMD.
• He states, "I like RBMD. I mean, it looks like the drug clearly works."
• He does mention a risk factor, noting that the long-term outlook for the "RAS world" (a class of cancer targets) is not 100% clear.

Takeaways

• The speaker is positive on RBMD due to promising clinical data for its drug.
• While bullish, he acknowledges some long-term uncertainty in the drug's specific market, suggesting that assigning a "huge valuation" now could be a mistake.

Spruce Biosciences (SPRB)

• The speaker is bullish on SPRB.
• He states he "like[s] SPRB a lot more than EQ" and has bought a small position.
• He frames it as a long-term position that could take two years to play out, as it depends on FDA approval and manufacturing improvements.

Takeaways

• SPRB is a long-term speculative biotech play for the speaker.
• This is not an "instant gratification" trade; investors should be prepared for a multi-year timeline for the thesis to potentially work out.

AltioGen (196170.KQ)

• The speaker is bullish and interested in this Korean company.
• He notes that it produces Hyaluronidase, a technology similar to what the successful company Halozyme uses.
• He is impressed by its stock performance, calling it a "rock star," and is surprised by its large market cap ($16 billion by his calculation).

Takeaways

• The speaker has identified AltioGen as a promising international company to follow.
• The interest stems from its technology being in a proven, valuable area of biotechnology and its strong stock performance.

Beyond Meat (BYND)

• The speaker is extremely bearish and has initiated a short position in BYND.
• His core thesis is that the company has a fundamentally broken business model, highlighted by its negative gross margin. He explains this means "the thing you're selling cost you more money than you're selling it for."
• He details the company's recent debt restructuring, where bondholders received a massive amount of new shares. He believes these bondholders will sell their shares, putting immense pressure on the stock price.
• He dismisses the recent rally, which was tied to a Walmart distribution expansion, as "Fugazi" news, pointing out that the company has made similar announcements in the past while revenue continued to decline.
• He views the stock's parabolic move as an opportunity to build a short position, stating, "I kind of hope it goes up, to be honest, just so I can keep piling in."

Takeaways

• The speaker sees Beyond Meat as a classic short-selling opportunity based on terrible fundamentals.
• The negative gross margin is a major red flag, indicating an unsustainable business.
• The recent rally is viewed as a "buyer squeeze" or retail mania, not a fundamental turn in the business, creating what he believes is an attractive entry point for a short trade. He has started a small short position and may add to it if the price rises further.

Palantir (PLTR)

• The speaker is bullish on Palantir.
• He states, "Palantir's a good company. I don't know why anyone wants to short Palantir."
• He praises its business model, where it saves clients money and takes a percentage of the savings, comparing it to a hedge fund's performance allocation.
• He highlights its impressive financial performance, noting that the "rate of change of their growth is positive," which is rare for a company of its size, and that it has a "50% cashflow margin."

Takeaways

• The speaker views Palantir as a high-quality company with a strong, unique business model and excellent financial metrics.
• He believes it is a mistake to short the stock, despite what some may see as a high valuation.

Korean Semiconductor Sector

• The speaker is exploring investment opportunities in Korean companies within the semiconductor supply chain.
• He believes there are "interesting things going on there" and that some stocks may be "wildly mispriced."
• He uses SK Hynix as a prime example of a Korean company benefiting from the AI boom, as it supplies critical memory for NVIDIA's GPUs. He notes SK Hynix has "gone parabolic."

Takeaways

• This is an emerging investment theme for the speaker.
• He suggests that there may be undervalued opportunities in the Korean market that are tied to the global AI and semiconductor trends.
• Investors interested in this theme could research companies in the Korean semiconductor ecosystem, similar to how SK Hynix is a key supplier to NVIDIA.

Bitcoin (BTC)

• The discussion centers on the threat that quantum computing poses to Bitcoin's underlying cryptography (SECP256K1).
• The speaker believes that at some point, a quantum computer running Shor's algorithm will be able to break Bitcoin's security.
• He also believes a "classical analytical solution" might be possible sooner than people think, partly due to advances in AI.
• He suggests a solution would be to fork Bitcoin to a quantum-resistant algorithm, but this presents challenges, such as what to do with "lost" coins like Satoshi's, which would become vulnerable.

Takeaways

• A long-term, existential risk for Bitcoin is the development of quantum computers.
• While the market is not currently pricing in this risk, it is a significant future threat that could undermine Bitcoin's value proposition as "hard money."
• The community's ability to coordinate a hard fork to quantum-resistant cryptography will be a critical test in the future.